AmCan Fertility Group provides the most advanced Third-Generation IVF technology available today. All embryos are screened by Preimplantation Genetic Screening (PGS)/Preimplantation Genetic Diagnosis (PGD) before transfer for diagnosis embryos of any potential abnormalities. Healthy screened embryos are then used for transfer, effectively reducing the risk of termination of pregnancy due to genetic diseases, improving the implantation rate of blastocysts and live birth rate after transfer, and promoting reproductive health.